Stock listing
OTC:CDBKF Cloudbreak Pharma, Inc. Stock
US listing (OTC) of Cloudbreak Pharma, Inc. · home listing HKEX:2592
Follow Cloudbreak Pharma, Inc. into a list and get an email when it puts out news.
Home listing price · HKEX:2592
$1.19 HKD 0.00 (0.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, HKEX:2592
- Day range
- $1.19 – $1.19 HKDNov 20, 2026
- Market cap
- $1.10B HKDAt the close on Nov 20, 2026 · price × 924.7M shares outstanding
- 52-week range
- $0.90 – $9.58 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $20,896 HKDMedian day 0 shares · 41 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:2592 · Home | $1.19 HKD | 0.00 (0.0%) | — | $1.19 | $1.19 | $1.19 | $1.19 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2592 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | 0.00 | 0.0% | $1.19 | $1.19 | $1.19 | 0 | |
| $1.19 | +0.025 | +2.1% | $1.165 | $1.21 | $1.165 | 18,500 | |
| $1.165 | -0.02 | -1.7% | $1.17 | $1.195 | $1.16 | 38,500 | |
| $1.185 | +0.005 | +0.4% | $1.18 | $1.195 | $1.18 | 56,500 | |
| $1.18 | +0.025 | +2.2% | $1.165 | $1.18 | $1.16 | 93,500 | |
| $1.155 | 0.00 | 0.0% | $1.15 | $1.165 | $1.15 | 43,000 | |
| $1.155 | +0.01 | +0.9% | $1.145 | $1.17 | $1.115 | 34,500 | |
| $1.145 | 0.00 | 0.0% | $1.14 | $1.145 | $1.14 | 32,500 | |
| $1.145 | -0.01 | -0.9% | $1.16 | $1.16 | $1.145 | 48,000 | |
| $1.155 | -0.04 | -3.3% | $1.195 | $1.195 | $1.155 | 71,500 | |
| $1.195 | 0.00 | 0.0% | $1.195 | $1.23 | $1.18 | 168,500 | |
| $1.195 | +0.035 | +3.0% | $1.15 | $1.23 | $1.15 | 71,000 | |
| $1.16 | -0.02 | -1.7% | $1.155 | $1.16 | $1.155 | 5,000 | |
| $1.18 | -0.02 | -1.7% | $1.20 | $1.225 | $1.16 | 128,000 | |
| $1.20 | +0.035 | +3.0% | $1.145 | $1.21 | $1.145 | 140,500 | |
| $1.165 | -0.005 | -0.4% | $1.145 | $1.175 | $1.14 | 43,000 |
- Ticker
- OTC:CDBKF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 13, 2026
Change of principal place of business in Hong Kong
Latest deck · Apr 8, 2026
Investor Presentation (April 2026)
Investor deck · 23 slides
Latest news
Change of principal place of business in Hong Kong
Nov 13, 2026
Closed $1.19 (0.0%) on Nov 17, 2026
Voluntary announcement - business update in relation to the topline results from the Phase 3 study of CBT-001 in patients with pterygium
Nov 4, 2026
Closed $1.19 (0.0%) on Nov 9, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Closed $1.19 (0.0%) on Nov 9, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 6, 2026
Closed $1.19 (0.0%) on Oct 7, 2026
Formation of an independent Special committee; delay in publication and despatch of 2026 interim report; and continued suspension of trading
Sep 30, 2026
Closed $1.19 (0.0%) on Oct 2, 2026
List of directors and their roles and functions
Sep 23, 2026
Closed $1.19 (0.0%) on Sep 24, 2026
Appointment of independent non-executive directors and continued suspension of trading
Sep 23, 2026
Closed $1.19 (0.0%) on Sep 24, 2026
Business updates and supplemental announcement in relation to 2025 annual report
Sep 18, 2026
Closed $1.19 (0.0%) on Sep 21, 2026
Suspension of trading
Sep 18, 2026
Closed $1.19 (0.0%) on Sep 21, 2026
Cloudbreak Pharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 15 in the last 12 months · 16 in all · newest Nov 13, 2026 · oldest 2025
- Decks
- 1 deck · latest Apr 8, 2026
Where Cloudbreak Pharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:2592 撥康視雲 · Home listing | HKEX | Hong Kong | HKD |
| OTC:CDBKF · This page | OTC | United States | USD |
Valuation
Price/book 2.3× against a median of 1.1×: 8th lowest of 9 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- $643.0M HKD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.3×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Cloudbreak Pharma, Inc. · HKEX:2592 | US$140.4M | US$82.03M | n/a | n/a | n/a | 2.3× | n/a | 0.0× | n/a |
| ProQR Therapeutics N.V. · NASDAQ:PRQR | US$146.8M | US$49.73M | n/a | 2.2× | n/a | 2.0× | −210.7% | 0.2× | 1.73 |
| ALX Oncology Holdings Inc. · NASDAQ:ALXO | US$146.6M | US$9.57M | n/a | n/a | n/a | 1.2× | n/a | 0.1× | 0.68 |
| Bicycle Therapeutics PLC · NASDAQ:BCYC | US$146.1M | −US$323.8M | n/a | −3.9× | n/a | 0.3× | −169.8% | 0.0× | 1.59 |
| BridgeBio Oncology Therapeutics, Inc. · NASDAQ:BBOT | US$145.3M | −US$46.23M | n/a | n/a | n/a | 0.5× | n/a | 0.0× | 1.49 |
| TYK Medicines, Inc. Class H · HKEX:2410 | US$144.9M | US$137.0M | n/a | n/a | n/a | 3.7× | n/a | 0.6× | n/a |
| Sutro Biopharma, Inc. · NASDAQ:STRO | US$142.8M | US$259.6M | n/a | 5.8× | n/a | n/a | −344.2% | n/a | 1.14 |
| VISEN Pharmaceuticals · HKEX:2561 | US$140.7M | US$91.29M | n/a | 29.8× | n/a | 1.4× | n/a | 0.3× | n/a |
| Protara Therapeutics, Inc. · NASDAQ:TARA | US$140.4M | US$15.77M | n/a | n/a | n/a | 1.0× | n/a | 0.0× | 1.12 |
| Scancell Holdings PLC · LSE:SCLP | US$140.2M | US$155.6M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Abeona Therapeutics Inc. · NASDAQ:ABEO | US$138.4M | US$15.29M | n/a | 0.4× | n/a | 1.1× | −160.3% | 0.1× | 1.00 |
| Median of the others | US$143.8M | US$32.75M | 2.2× | 1.1× | −190.2% | 0.1× | 1.14 |
Team and board
| Officer | Role |
|---|---|
| Jinsong Ni | Founder, Chief Executive Officer |
| Van Dinh | Chief Operating Officer |
| Abu Abraham | Chief Medical Officer |
| Elizabeth Capan | Chief Patent Officer |
| Greg Brooks | Chief Commercial Officer |
| Michael Rowe | Chief Business Officer |
| Rong Yang | Chief Scientific Officer |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (April 2026) | Investor deck | 23 slides | Apr 8, 2026 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 0 | 10.0M | 0 | 0 |
| Research and development | 66.8M | 37.9M | 27.5M | 15.3M |
| Selling, general and administrative | 40.9M | 9.49M | 2.62M | 5.42M |
| Operating income | -107.4M | -37.2M | -35.8M | -23.7M |
| Depreciation and amortization | 620.0K | 1.23M | 829.0K | 329.0K |
| EBITDA | -106.8M | -36.0M | -34.9M | -23.4M |
| Interest expense | 23.0K | 27.0K | 275.0K | 31.0K |
| Income before tax | -67.8M | -98.3M | -129.4M | -66.8M |
| Net income | -67.7M | -99.1M | -129.4M | -66.8M |
| Earnings per share, basic | -0.08 | -0.12 | -0.15 | -0.08 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash and equivalents | 40.1M | 34.9M | 52.7M | 15.9M |
| Short-term investments | 18.2M | 7.50M | 63.2M | |
| Inventory | 110.0K | 0 | ||
| Current assets | 64.3M | 37.5M | 61.5M | 80.1M |
| Total assets | 66.6M | 40.0M | 64.8M | 82.1M |
| Accounts payable | 836.0K | 1.76M | 2.10M | 1.23M |
| Current liabilities | 6.02M | 391.3M | 327.4M | 226.7M |
| Total liabilities | 6.12M | 391.6M | 327.6M | 227.3M |
| Shareholders' equity | 60.5M | -351.5M | -262.8M | -145.2M |
| Shares outstanding | 844.6M | 838.9M | 838.9M | 838.9M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash from operations | -51.5M | -26.5M | -22.5M | -20.1M |
| Capital spending | -18.2M | -155.0K | -2.21M | -778.0K |
| Free cash flow | -69.7M | -26.7M | -24.7M | -20.8M |
| Change in cash | 5.02M | -17.6M | 36.9M | -64.2M |
Filings
Cap table
Built by 6ix from Cloudbreak Pharma, Inc.’s releases
- Common shares
- 924,692,316
- Fully diluted
- 924,692,316
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 924,692,316 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 924,692,316 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Abu Abraham | Chief Medical Officer · Since at least Jun 22, 2026 |
| Elizabeth Capan | Chief Patent Officer · Since at least Nov 5, 2026 |
| Greg Brooks | Chief Commercial Officer · Since at least Nov 5, 2026 |
| Jinsong Ni | Founder, Chief Executive Officer · Since at least May 12, 2026 |
| Michael Rowe | Chief Business Officer · Since at least Nov 5, 2026 |
| Rong Yang | Chief Scientific Officer · Since at least Nov 5, 2026 |
| Van Dinh | Chief Operating Officer · Since at least Nov 5, 2026 |
Log in to ask 6ix AI your own questions about Cloudbreak Pharma, Inc.